Stat3 upregulates leucine-rich repeat-containing G protein-coupled receptor 4 expression in osteosarcoma cells

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Liu, Jia ^a   Wei, Wei ^b   Guo, Chang An ^a   Han, Ning ^a   Pan, Jian Feng ^a   Fei, Teng ^a   Yan, Zuo Qin ^a  

^a FUDAN UNIVERSITY   (China)

^b Chinese Academy of Sciences   (China)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 6; LEUCINE RICH REPEAT CONTAINING G PROTEIN COUPLED RECEPTOR 4; SMALL INTERFERING RNA; STAT3 PROTEIN; UNCLASSIFIED DRUG; LGR4 PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN;

ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; OSTEOSARCOMA CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN TARGETING; SIGNAL TRANSDUCTION; UPREGULATION; BIOSYNTHESIS; BONE TUMOR; DRUG EFFECT; GENETICS; METABOLISM; MICROARRAY ANALYSIS; OSTEOSARCOMA; PATHOLOGY; PROMOTER REGION; TUMOR CELL LINE;

BONE NEOPLASMS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; MICROARRAY ANALYSIS; OSTEOSARCOMA; PROMOTER REGIONS, GENETIC; RECEPTORS, G-PROTEIN-COUPLED; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR;

EID: 84896081988     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/310691     Document Type: Article

References (24)

1. Reich N. C., Liu L., Tracking STAT nuclear traffic. Nature Reviews Immunology 2006 6 8 602 612 2-s2.0-33746570647 10.1038/nri1885 (Pubitemid 44134093)
2. Kirk R., Targeted therapies: STAT3 and EGFR target resistance. Nature Reviews Clinical Oncology 2012 9 489 10.1038/nrclinonc.2012.140
3. Yoshimura A., Naka T., Kubo M., SOCS proteins, cytokine signalling and immune regulation. Nature Reviews Immunology 2007 7 6 454 465 2-s2.0-34249660614 10.1038/nri2093 (Pubitemid 46834848)
4. Hedvat M., Huszar D., Herrmann A., Gozgit J. M., Schroeder A., Sheehy A., Buettner R., Proia D., Kowolik C. M., Xin H., Armstrong B., Bebernitz G., Weng S., Wang L., Ye M., McEachern K., Chen H., Morosini D., Bell K., Alimzhanov M., Ioannidis S., McCoon P., Cao Z. A., Yu H., Jove R., Zinda M., The JAK2 inhibitor AZD1480 potently blocks stat3 signaling and oncogenesis in solid tumors. Cancer Cell 2009 16 6 487 497 2-s2.0-70949094349 10.1016/j.ccr.2009.10.015
5. Kortylewski M., Xin H., Kujawski M., Lee H., Liu Y., Harris T., Drake C., Pardoll D., Yu H., Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell 2009 15 2 114 123 2-s2.0-58649119388 10.1016/j.ccr.2008.12.018
6. Yu H., Pardoll D., Jove R., STATs in cancer inflammation and immunity: a leading role for STAT3. Nature Reviews Cancer 2009 9 11 798 809 2-s2.0-70350500225 10.1038/nrc2734
7. Lee H., Herrmann A., Deng J.-H., Kujawski M., Niu G., Li Z., Forman S., Jove R., Pardoll D. M., Yu H., Persistently activated Stat3 maintains constitutive NF- B activity in tumors. Cancer Cell 2009 15 4 283 293 2-s2.0-63249092765 10.1016/j.ccr.2009.02.015
8. Tu B., Du L., Fan Q. M., Tang Z., Tang T. T., STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma. Cancer Letters 2012 325 80 88
9. Lee H., Deng J., Kujawski M., Yang C., Liu Y., Herrmann A., Kortylewski M., Horne D., Somlo G., Forman S., Jove R., Yu H., STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. Nature Medicine 2010 16 12 1421 1428 2-s2.0-78649982367 10.1038/nm.2250
10. Deng J., Liu Y., Lee H., S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. Cancer Cell 2012 21 642 654
11. de Lau W., Barker N., Low T. Y., Koo B.-K., Li V. S. W., Teunissen H., Kujala P., Haegebarth A., Peters P. J., van de Wetering M., Stange D. E., van Es J., Guardavaccaro D., Schasfoort R. B. M., Mohri Y., Nishimori K., Mohammed S., Heck A. J. R., Clevers H., Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 2011 476 7360 293 297 2-s2.0-80051926611 10.1038/nature10337
12. Glinka A., Dolde C., Kirsch N., Huang Y.-L., Kazanskaya O., Ingelfinger D., Boutros M., Cruciat C.-M., Niehrs C., LGR4 and LGR5 are R-spondin receptors mediating Wnt/ β -catenin and Wnt/PCP signalling. EMBO Reports 2011 12 10 1055 1061 2-s2.0-80053560465 10.1038/embor.2011.175
13. Niehrs C., The complex world of WNT receptor signalling. Nature Reviews Molecular Cell Biology 2012 13 767 779
14. Qian Y., Liu S., Guan Y., Lgr4-mediated Wnt/ β -catenin signaling in peritubular myoid cells is essential for spermatogenesis. Development 2013 140 1751 1761
15. Luo J., Zhou W., Zhou X., Li D., Weng J., Yi Z., Cho S. G., Li C., Yi T., Wu X., Li X.-Y., de Crombrugghe B., Höök M., Liu M., Regulation of bone formation and remodeling by G-protein-coupled receptor 48. Development 2009 136 16 2747 2756 2-s2.0-69049090918 10.1242/dev.033571
16. Mohri Y., Kato S., Umezawa A., Okuyama R., Nishimori K., Impaired hair placode formation with reduced expression of hair follicle-related genes in mice lacking Lgr4. Developmental Dynamics 2008 237 8 2235 2242 2-s2.0-49449109436 10.1002/dvdy.21639
17. Weng J., Luo J., Cheng X., Jin C., Zhou X., Qu J., Tu L., Ai D., Li D., Wang J., Martin J. F., Amendt B. A., Liu M., Deletion of G protein-coupled receptor 48 leads to ocular anterior segment dysgenesis (ASD) through down-regulation of Pitx2. Proceedings of the National Academy of Sciences of the United States of America 2008 105 16 6081 6086 2-s2.0-43149099246 10.1073/pnas.0708257105 (Pubitemid 351758402)
18. Oyama K., Mohri Y., Sone M., Nawa A., Nishimori K., Conditional knockout of Lgr4 leads to impaired ductal elongation and branching morphogenesis in mouse mammary glands. Sexual Development 2011 5 4 205 212 2-s2.0-79960945902 10.1159/000329476
19. Li X.-Y., Lu Y., Sun H.-Y., Wang J.-Q., Yang J., Zhang H.-J., Fan N.-G., Xu J., Jiang J.-J., Liu R.-Y., Li D.-L., Liu M.-Y., Ning G., G protein-coupled receptor 48 upregulates estrogen receptor α expression via cAMP/PKA signaling in the male reproductive tract. Development 2010 137 1 151 157 2-s2.0-73649092120 10.1242/dev.040659
20. Siwko S., Lai L., Weng J., Liu M., Lgr4 in ocular evelopment and glaucoma. Journal of Ophthalmology 2013 2013 9 987494 10.1155/2013/987494
21. Styrkarsdottir U., Thorleifsson G., Sulem P., Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits. Nature 2013 497 517 520
22. Gao Y., Kitagawa K., Hiramatsu Y., Kikuchi H., Isobe T., Shimada M., Uchida C., Hattori T., Oda T., Nakayama K., Nakayama K. I., Tanaka T., Konno H., Kitagawa M., Up-regulation of GPR48 induced by down-regulation of p27Kip1 enhances carcinoma cell invasiveness and metastasis. Cancer Research 2006 66 24 11623 11631 2-s2.0-33846209564 10.1158/0008-5472.CAN-06-2629 (Pubitemid 46094173)
23. Wu J., Xie N., Xie K., GPR48, a poor prognostic factor, promotes tumor metastasis and activates β -catenin/TCF signaling in colorectal cancer. Carcinogenesis 2013 34 12 2861 2869 10.1093/carcin/bgt229
24. Du B., Luo W., Li R., Lgr4/Gpr48 negatively regulates TLR2/4-associated pattern recognition and innate immunity by targeting CD14 expression. The Journal of Biological Chemistry 2013 288 15131 15141 10.1074/jbc.M113.455535